Amlodipine and Ingrezza drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Amlodipine (amlodipine besylate) and Ingrezza (valbenazine tosylate). Common drug interactions include urinary tract infection among females and somnolence among males.
The phase IV clinical study analyzes what interactions people have when they take Amlodipine and Ingrezza. It is created by eHealthMe based on reports of 314 people who take the same drugs from the FDA, and is updated regularly.
What is Amlodipine?
Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,830 Amlodipine users. Check the latest studies of Amlodipine.
What is Ingrezza?
Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
314 people who take Amlodipine and Ingrezza together, and have interactions are studied.
What are the common drug interactions of Amlodipine and Ingrezza, by gender? *
What are the common drug interactions of Amlodipine and Ingrezza, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Amlodipine and Ingrezza?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Amlodipine (354,830 reports)
- Ingrezza (23,666 reports)
Browse all drug interactions of Amlodipine and Ingrezza:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Amlodipine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ingrezza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Amlodipine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ingrezza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate and valbenazine tosylate (the active ingredients of Amlodipine and Ingrezza, respectively), and Amlodipine and Ingrezza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chest Pain in Flovent Hfa, how severe and when it was recovered? - 3 seconds ago
- Glaucoma and Ocular Hyperaemia - 4 seconds ago
- Famotidine and Acetylsalicylic Acid drug interactions for women aged 30-39 - 6 seconds ago
- Drug interactions of Miralax and Tysabri - 7 seconds ago
- Kidney Infection (Pyelonephritis) and drugs of ingredients of metoprolol succinate - 10 seconds ago
- Vivitrol and Drowsiness for Men aged 40-49 - 13 seconds ago
- Vivitrol and Can'T Stay Wake for Men aged 40-49 - 13 seconds ago
- Vivitrol and Sleepiness for Men aged 40-49 - 14 seconds ago
- Vivitrol and Sleepy for Men aged 40-49 - 14 seconds ago
- Vivitrol and Drowsiness, Hypersomnia, Sleepiness - During The Day, Somnolence for Men aged 40-49 - 14 seconds ago